Jeanne Freddura

Corporate Officer/Principal presso COMMUNITY REDEVELOPMENT INC.

Consumer Services

Finance

Health Technology

Posizioni attive di Jeanne Freddura

Società	Posizione	Inizio	Fine
COMMUNITY REDEVELOPMENT INC.	Corporate Officer/Principal	02/02/2022	-

Società	Posizione	Inizio	Fine
Syntimmune, Inc. Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.	Comptroller/Controller/Auditor	-	-

Cambridge College	Undergraduate Degree
Harvard University	Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	1
Comptroller/Controller/Auditor	1
Undergraduate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
COMMUNITY REDEVELOPMENT INC.	Finance

Aziende private	1
Syntimmune, Inc. Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.	Health Technology

Aziende private

Health Technology